Growth GuidanceProfound reported Q4 results mostly in line with expectations and guided to 70%-75% growth this year, with the opportunity to reach triple-digit growth rates next year and beyond.
Reimbursement RatesTULSA received a substantially higher reimbursement rate for 2025 from CMS than RARP, potentially making it more profitable for many institutions.
Tariff And Trade ComplianceProfound is almost certainly unlikely to face any challenges on tariff concerns as the company is USMCA compliant, allowing their products to be traded duty-free.